Recognizing the heterogeneity seen in individuals with SAS from our experience at the SATB2-associated syndrome international clinic at Arkansas Children's Hospital, a referral center for individuals with SAS, we propose a severity-scoring system for the quantitative and standardized assessment of clinical severity in individuals with SAS. This evidence concerns the gene SATB2 and Down syndrome.